Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Adult, ALL, AML, CRS, Leukemia, Diseases, neurotoxicity, Non-Biological, CAR-Ts, Therapies, Mantle Cell Lymphoma, Adverse Events, Non-Hodgkin Lymphoma, B-Cell Lymphoma, DLBCL, immunotherapy, Lymphoid Malignancies, Study Population, Myeloid Malignancies, Clinically relevant, transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Adult, ALL, AML, CRS, Leukemia, Diseases, neurotoxicity, Non-Biological, CAR-Ts, Therapies, Mantle Cell Lymphoma, Adverse Events, Non-Hodgkin Lymphoma, B-Cell Lymphoma, DLBCL, immunotherapy, Lymphoid Malignancies, Study Population, Myeloid Malignancies, Clinically relevant, transplantation
Monday, December 7, 2020: 1:30 PM-3:00 PM
Moderators:
Matthew J Frigault, MD, MSc, Massachusetts General Hospital
and
Rayne H. Rouce, MD, Clinical Care Center-Texas Children's Hospital
Disclosures:
Rouce: Tessa Therapeutics: Other, Research Funding; Novartis: Honoraria.
1:30 PM
1:45 PM
2:00 PM
2:15 PM
2:30 PM
2:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH